新的染色盒2抑制降低了瘤进展的速度
Lindsay W Brubaker1, Donald S Backos2, Vu T Nguyen2
1Department of Obstetrics & Gynecology, Division of Gynecologic Oncology, The University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Expert opinion on therapeutic targets
|May 27, 2023
概括
用新型来阻断Chromobox2 (CBX2) 功能,可以抑制癌细胞的生长和瘤的进展. 这种方法针对表观遗传调节器CBX2,提供了针对癌症和化疗耐药性的新策略.
科学领域:
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 聚合体抑制器复合体1 (PRC1) 是一种对发育至关重要的表观遗传调节器.
- 异常的PRC1亚单元表达,像Chromobox2 (CBX2),驱动癌症的进展和化学抵抗.
- CBX2 识别压制性组质素标记 (H3K27me3,H3K9me2) 并在各种癌症中过度表达.
研究的目的:
- 研究抑制CBX2读者功能作为抗癌策略的潜力.
- 设计和验证可阻断CBX2与其标相互作用的.
主要方法:
- 对CBX2的染色体和A/T链DNA结合域的计算同质模型.
- 设计和合成针对这些域的阻断.
- 在卵巢癌模型中体外和体内测试的疗效.
主要成果:
- 阻断CBX2可以显著抑制2D和3D卵巢癌细胞的生长.
- 这些降低了关键的CBX2基因的下调.
- 在体内研究表明,酸会抑制瘤的生长.
结论:
- 用特定的酸针对CBX2的阅读器功能是一种可行的抗癌治疗方法.
- 阻断CBX2在抑制癌症进展方面表现有前途,并可能克服化疗耐药性.
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
The Intrinsic Apoptotic Pathway
6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Epigenetic Regulation
31.1K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.1K
Inheritance of Chromatin Structures
6.3K
Epigenetics is the study of inherited changes in a cell's phenotype without changing the DNA sequences. It provides a form of memory for the differential gene expression pattern to maintain cell lineage, position-effect variegation, dosage compensation, and maintenance of chromatin structures such as telomeres and centromeres. For example, the structure and location of the centromere on chromosomes are epigenetically inherited. Its functionality is not dictated or ensured by the underlying...
6.3K


